BDBM224078 7-[(trans-4- methylcyclohexyl)methyl]- 8-[4-(1- methylethyl)pyridin-2- yl]-6-{[(1r)-2,2,2- trifluoro-1- methylethyl]amino}-7h- purine-2-carboxylic acid::US9540377, 15.22

SMILES CC(C)c1ccnc(-c2nc3nc(C(=O)O)nc(N[C@H](C)C(F)(F)F)c3n2C[C@H]2CC[C@H](C)CC2)c1

InChI Key InChIKey=PFQJJZNEQQLGJK-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 224078   

TargetE3 ubiquitin-protein ligase Mdm2 [17-125](Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 224078BDBM224078(US9540377, 15.22 | 7-[(trans-4- methylcyclohexyl)m...)
Affinity DataIC50: 17.9nMT: 2°CAssay Description:An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2018
Entry Details
US Patent